Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
出版年份 2023 全文链接
标题
Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review
作者
关键词
-
出版物
BMC Cardiovascular Disorders
Volume 23, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-01
DOI
10.1186/s12872-023-03578-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Endothelial Dysfunction, Atherosclerosis, and Increase of von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine
- (2021) Ferdows Atiq et al. THROMBOSIS AND HAEMOSTASIS
- Nuclear magnetic resonance lipoproteins are associated with carotid atherosclerosis in type 1 diabetes and pre‐eclampsia
- (2020) Antonio J. Amor et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: the LipoLab Study
- (2020) Vicente Pallarés‐Carratalá et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients
- (2019) Chun-Yu Chang et al. Journal of Clinical Medicine
- Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Maigeng Zhou et al. LANCET
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Integrated Small Dense Low-density Lipoprotein Profile in Cardiovascular Disease and Cancer: A Longitudinal Study
- (2019) MARIA NOTARNICOLA et al. ANTICANCER RESEARCH
- Specific Nuclear Magnetic Resonance Lipoprotein Subclass Profiles and Central Arterial Stiffness in Type 1 Diabetes Mellitus: A Case Control Study
- (2019) Gemma Llauradó et al. Journal of Clinical Medicine
- Human mast cell neutral proteases generate modified LDL particles with increased proteoglycan binding
- (2018) Katariina Maaninka et al. ATHEROSCLEROSIS
- Gender differences in LDL- and HDL-cholesterol subfractions in patients after the acute ischemic stroke and their association with oxidative stress markers
- (2018) Ingrid Žitňanová et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals
- (2018) Ehimen C Aneni et al. Journal of Atherosclerosis and Thrombosis
- Range of L5 LDL levels in healthy adults and L5’s predictive power in patients with hyperlipidemia or coronary artery disease
- (2018) Chih-Sheng Chu et al. Scientific Reports
- Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
- (2016) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia
- (2015) Eliano Pio Navarese et al. ANNALS OF INTERNAL MEDICINE
- Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation
- (2015) M.-Y. Shen et al. BLOOD
- Lipid lowering with PCSK9 inhibitors
- (2014) Razvan T. Dadu et al. Nature Reviews Cardiology
- Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke
- (2013) MedineCumhur Cure et al. Annals of Indian Academy of Neurology
- Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
- (2013) Stanley Ip ANNALS OF INTERNAL MEDICINE
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Lipoprotein Subfractions and Coronary Artery Calcium In Patient at Intermediate Cardiovascular Risk
- (2012) Borut Jug et al. AMERICAN JOURNAL OF CARDIOLOGY
- Small dense LDL: An emerging risk factor for cardiovascular disease
- (2012) Satoshi Hirayama et al. CLINICA CHIMICA ACTA
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Low-density lipoprotein particle number predicts coronary artery calcification in asymptomatic adults at intermediate risk of cardiovascular disease
- (2011) Kimberly Buff Prado et al. Journal of Clinical Lipidology
- Lipoprotein Subclasses Determined by Nuclear Magnetic Resonance Spectroscopy and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
- (2010) C. P. CHUNG et al. JOURNAL OF RHEUMATOLOGY
- LDL and HDL subclasses in acute ischemic stroke: Prediction of risk and short-term mortality
- (2009) Aleksandra Zeljkovic et al. ATHEROSCLEROSIS
- Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
- (2009) Samia Mora et al. CIRCULATION
- The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors
- (2009) Julian F. Thayer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Comparability of methods for LDL subfraction determination: A systematic review
- (2008) Mei Chung et al. ATHEROSCLEROSIS
- Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome
- (2008) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Is it LDL particle size or number that correlates with risk for cardiovascular disease?
- (2008) H. Robert Superko et al. Current Atherosclerosis Reports
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started